- $441.73m
- $442.91m
- 49
- 39
- 66
- 51
2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Total Revenue | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||
Total Operating Expenses | 0.057 | 4.42 | 3.1 |
Operating Profit | -0.057 | -4.42 | -3.1 |
Total Net Non Operating Interest Income / Expense | |||
Net Income Before Taxes | -0.057 | 9.76 | 34.8 |
Net Income After Taxes | -0.057 | 9.76 | 34.8 |
Net Income Before Extraordinary Items | |||
Net Income | -0.057 | 9.76 | 34.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | -0.057 | 9.76 | 34.8 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | -0.001 | 0.113 | 0.404 |
Dividends per Share |